Basic Information
SOJOURN INHALATION ANAESTHETIC LIQUID 100%
INHALANT
Regulatory Information
SIN14780P
May 8, 2015
Prescription Only
Therapeutic
RESPIRATORY (INHALATION)
August 10, 2023
June 3, 2025
XN01AB08
Company Information
Active Ingredients
Strength: 100% v/v
Detailed Information
Contraindications
**Contraindications** Sevoflurane should not be used in patients with known or suspected sensitivity to Sevoflurane or to other halogenated inhalational anaesthetics (e.g. history of hepatotoxicity, usually including elevated liver enzymes, fever, leukocytosis and/or eosinophilia temporally related to anaesthesia with one of these agents). Sevoflurane is also contraindicated in patients known or suspected genetic susceptibility to malignant hyperthermia.
Indication Information
**Indications** For induction and maintenance of general anaesthesia in-patient and out-patient surgery in both adults and children.